This article seems to miss the bigger picture -- why is Lucentis 40x more expensive than Avastin? The answer is that drugs aren't priced by how much they cost

This article seems to miss the bigger picture -- why is Lucentis 40x more expensive than Avastin? The answer is that drugs aren't priced by how much they cost to manufacture a dose -- nor should they be! Roughly, they're priced by the cost of R&D (a fixed cost) and the benefit to patients (a fixed benefit per patient). So it makes complete sense that Lucentis is more expensive, because the does size is so much smaller. It's still vastly less expensive to get eye treatment with Lucentis than cancer treatment with Avastin, which runs at ~$100,000/year.